We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Maryland state legislature approved a bill to ban excessive price increases for generics and off-patent drugs, sending it to the state’s governor for final approval. Read More
In a Senate committee markup scheduled for May 10, lawmakers will consider the next generation of the FDA’s generic user fee program, using dollar amounts negotiated over the last two years with industry. Read More
The FDA’s proposed plan for spending the $500 million allocated by the 21st Century Cures Act through fiscal 2025 prioritizes patient-focused drug development, qualification of biomarkers, and the use of real-world evidence. Read More
The U.K.’s Medicines and Healthcare products Regulatory Agency laid out its top 10 priorities for 2017 and 2018 — including ensuring GMP compliance and quality throughout supply chains. Read More
The Senate on Thursday approved the House version of a spending bill for fiscal 2017 in a 79-18 vote — including a modest increase in FDA funds through September. The president was expected to sign the bill into law quickly. Read More
With a 309-118 vote, the U.S. House approved a bill Wednesday that would boost FDA funding and keep the government running through the end of the fiscal year. Read More